Arcoma
8.34 SEK
+3.99 %
Less than 1K followers
ARCOMA
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Arcoma
P/E
Median 2019-2025
EV/S
Median 2019-2021
EV/EBIT
Median 2019-2021
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 19.80 | 22.00 | 13.00 | 7.68 | 7.95 | 10.75 | 7.34 |
| Shares | 12.6 | 12.8 | 13.1 | 13.2 | 13.2 | 13.2 | 14.3 |
| Market cap | 250.4 | 281.9 | 169.7 | 101.3 | 104.8 | 141.7 | 105.0 |
| Enterprise value | 249.2 | 277.3 | 171.5 | - | - | - | - |
| EV/S | 1.9 | 2.4 | 1.5 | - | - | - | - |
| EV/EBITDA | 19.0 | 40.2 | neg. | - | - | - | - |
| EV/EBIT | 27.4 | 77.1 | neg. | - | - | - | - |
| P/E | 39.4 | 196.4 | neg. | 54.9 | 41.8 | 12.6 | 21.0 |
| P/B | 5.57 | 5.68 | 3.85 | 2.21 | 2.15 | 2.39 | 1.41 |
| P/S | 1.9 | 2.4 | 1.4 | 0.8 | 0.6 | 0.9 | 0.8 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 54.1 % | 52.2 % | 55.6 % | 45.7 % | 59.4 % | 73.7 % | 77.3 % |
| Gearing ratio | 2.4 % | 8.1 % | 15.2 % | 14.9 % | 8.0 % | - | - |